Clinical Trial

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-05-13.
Trial Details
NCT Number NCT03949049
Lead Sponsor Sherief Abd-Elsalam
Conditions Neonatal Hypoxia
Enrollment 40 participants
Start Date 2019-02-01
Primary Completion 2029-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2019-05-29